Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication
Artículo científico (JournalArticle)
Ligand engineering enables efficient intracellular chemiluminescence-driven activation of luminol-functionalised Ir(iii) complexes
Cyclometalated Ir(iii) complexes are promising photosensitisers (PSs) for photodynamic therapy (PDT), yet their dependence on external light remains a major limitation for the treatment of deep or poorly accessible tumours. Here, we report on a modular chemiluminescence-activated PDT platform based on luminol-functionalised Ir(iii) complexes capable of undergoing chemiluminescence resonance energy transfer (CRET) without external light irradiation. A systematic 2 × 2 ligand matrix combining two cyclometalating C^N ligands and two electronically distinct N^N ligands was developed to elucidate the influence of ligand design on excited-state properties, CRET efficiency, and biological activity. Photophysical studies revealed that cyclometalated ligand scaffolds strongly influence excited-state localisation and emission behaviour, with luminol conjugation inducing substantial reorganisation of the emissive states in selected metal complexes. Excitation–emission mapping, spectral overlap analysis, and TD-DFT calculations support efficient intramolecular energy transfer between luminol-derived chemiluminescence and the Ir(iii) PS, particularly for the phenylbenzothiazole-based derivatives. Biological evaluation demonstrated negligible dark toxicity together with efficient photoinduced cytotoxicity upon 450 nm irradiation. Importantly, luminol-functionalised metal complexes exhibited significant intracellular activation under chemiluminescent conditions, whereas the corresponding non-luminol analogues remained inactive, confirming the essential role of the luminol unit in CRET-mediated activation. Mechanistic studies revealed ligand-dependent differences in cellular localisation, mitochondrial response, and intracellular ROS generation. The radical-based ROS profile observed under CRET conditions is consistent with a greater contribution of type I-like ROS pathways compared with conventional photoactivation. Finally, CRET-mediated activation was maintained in 3D multicellular tumour spheroids under conditions where external photoactivation showed limited effects, highlighting the potential of internally activated PDT strategies in tumour-like environments where light penetration may be challenging. Collectively, this work establishes design principles governing chemiluminescence-driven activation of metal-based PSs and demonstrates that single-luminol Ir(iii) conjugates constitute a viable molecular platform for CRET-mediated PDT.